3 Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks With a Strong Future Roadmap: Suraksha Diagnostic, JG Chemicals and Jubilant FoodWorks

Diagnostic chain, zinc oxide maker and pizza chain stocks give investors exposure to health testing, industrial chemicals and food outlets used every day. Volumes, store additions and margins decide how much of that demand turns into profit.

Readers comparing diagnostic chain, zinc oxide maker and pizza chain stocks should weigh growth, margins, cash flow and valuation together instead of leaning on any single number.

This list covers three diagnostic chain, zinc oxide maker and pizza chain stocks: Suraksha Diagnostic for diagnostic and pathology testing through a network of labs and collection centres, JG Chemicals for zinc oxide used in tyres, ceramics, paints and other industrial products and Jubilant FoodWorks for pizza and other quick-service restaurant brands with a large store network. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

What Are Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks?

Diagnostic chain, zinc oxide maker and pizza chain stocks are shares of companies that run diagnostics, make chemicals or operate restaurants. Results depend on volumes, store additions and margins, so margins and cash flow separate the stronger names.

Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three diagnostic chain, zinc oxide maker and pizza chain stocks as of the 14 Oct 2026 close.

Among healthcare and consumer stocks, valuations sit close to their industry P/E multiples.

Valuation matters here because diagnostic chain, zinc oxide maker and pizza chain stocks can look attractive on growth and still look expensive on earnings.

Why Do Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks Have a Strong Roadmap in India?

Diagnostic chain, zinc oxide maker and pizza chain stocks have a strong roadmap in India because rising health checks, industrial chemical demand and eating out keep adding volumes for these firms. Three drivers stand out.

• Preventive health: More people test early and often.
• Industrial demand: Tyres, paints and ceramics need zinc oxide.
• Eating out: Quick-service outlets reach more towns.

Suraksha Diagnostic: Diagnostic Labs Drive the Pipeline

Suraksha Diagnostic's roadmap rests on diagnostic and pathology testing through a network of labs and collection centres, with rising health screening supporting test volumes.

Revenue grew from Rs 225.50 crore in FY22 to Rs 313.58 crore in FY26, a 39.1% rise, and FY26 revenue was 22.5% higher than FY25. FY26 net profit rose 1.4% to Rs 31.40 crore. Over four years, net profit rose from Rs 23.75 crore in FY22 to Rs 31.40 crore. In Q1 FY27, revenue grew 20.7% to Rs 88.74 crore, and net profit rose 40.0% to Rs 12.85 crore. Operating margin was 32.01% in FY26 and 35.97% in Q1 FY27 against 33.97% a year earlier.

Debt to equity is 0.53 and return on equity is 13.15%. FY26 operating cash flow was Rs 81.83 crore against capital expenditure of Rs 67.34 crore. Suraksha Diagnostic paid a dividend of Rs 0.05 per share for FY26, a yield of 0.02%. At a P/E of 46.05 against an industry P/E of 62.79, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 35.97% against 32.01% for FY26, so margin stability is the figure to follow as volumes grow.

JG Chemicals: Zinc Oxide Demand Builds the Next Leg

JG Chemicals' roadmap rests on zinc oxide used in tyres, ceramics, paints and other industrial products, with steady industrial demand supporting volumes.

Revenue grew from Rs 623.05 crore in FY22 to Rs 988.77 crore in FY26, a 58.7% rise, and FY26 revenue was 15.2% higher than FY25. FY26 net profit rose 2.8% to Rs 68.65 crore. Over four years, net profit rose from Rs 43.13 crore in FY22 to Rs 68.65 crore. In Q1 FY27, revenue grew 43.8% to Rs 318.38 crore, and net profit rose 59.7% to Rs 26.12 crore. Operating margin was 10.09% in FY26 and 11.48% in Q1 FY27 against 10.65% a year earlier.

Debt to equity is 0.01 and return on equity is 12.47%. FY26 operating cash flow was Rs 43.57 crore against capital expenditure of Rs 39.03 crore. The dividend yield is 0.16%. At a P/E of 31.94 against an industry P/E of 36.60, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 11.48% against 10.09% for FY26, so margin stability is the figure to follow as volumes grow.

Jubilant FoodWorks: Domino's Store Network Anchors the Roadmap

Jubilant FoodWorks' roadmap rests on Domino's Pizza stores across India and neighbouring markets, along with newer food brands, with store additions and delivery reach supporting sales.

Revenue grew from Rs 4,437.48 crore in FY22 to Rs 9,586.64 crore in FY26, a 116.0% rise, and FY26 revenue was 17.2% higher than FY25. FY26 net profit rose 54.4% to Rs 386.03 crore. In Q1 FY27, revenue grew 13.6% to Rs 2,588.34 crore, and net profit rose 6.0% to Rs 100.03 crore. Operating margin was 20.96% in FY26 and 20.37% in Q1 FY27 against 20.21% a year earlier.

Debt to equity is 2.14 and return on equity is 18.69%. FY26 operating cash flow was Rs 1,893.55 crore against capital expenditure of Rs 1,009.93 crore. Jubilant FoodWorks paid a dividend of Rs 1.2 per share for FY26, a yield of 0.28%. At a P/E of 62.77 against an industry P/E of 61.79, the stock trades in line with its industry multiple.

What to watch: Debt to equity of 2.14 is on the higher side, and net profit margin is only 4.0%, so small cost changes move earnings.

Best Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks in India: Suraksha Diagnostic vs JG Chemicals vs Jubilant FoodWorks on Key Financials

Among the best diagnostic chain, zinc oxide maker and pizza chain stocks in India, Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; JG Chemicals leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; Jubilant FoodWorks leads on FY26 net profit growth and return on equity. The table puts the numbers side by side.

Healthcare and consumer earnings follow volumes, store additions and margins, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen diagnostic chain, zinc oxide maker and pizza chain stocks and shortlist diagnostic chain, zinc oxide maker and pizza chain stocks to buy.

1. Compare each stock's P/E with its industry P/E, which differs by company here.
2. Check revenue growth, operating margin and cash flow together.
3. Check whether revenue growth is turning into profit growth, not only sales.
4. Read operating cash flow against capital expenditure to see how growth is funded.
5. Watch debt to equity and interest cover before sizing a position.
6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these diagnostic chain, zinc oxide maker and pizza chain stocks

Risks to Consider Before Investing in Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks

• Debt and cash flow: Jubilant FoodWorks has debt to equity of 2.14.
• Consumer demand: Spending patterns can shift sales between quarters.
• Input costs: Changes in raw material prices can affect margins.
• Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track Suraksha Diagnostic, JG Chemicals and Jubilant FoodWorks live.

Final Take: Which Stock Has the Strongest Roadmap?

These three healthcare and consumer stocks cover diagnostics, zinc oxide and quick-service restaurants. Suraksha Diagnostic leads on FY26 revenue growth and FY26 operating margin; JG Chemicals leads on Q1 FY27 revenue growth and Q1 FY27 net profit growth; Jubilant FoodWorks leads on FY26 net profit growth and return on equity.

Across diagnostic chain, zinc oxide maker and pizza chain stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the diagnostic chain, zinc oxide maker and pizza chain stocks to buy discussed here.

FAQs on Diagnostic Chain, Zinc Oxide Maker and Pizza Chain Stocks

Which are the best diagnostic chain, zinc oxide maker and pizza chain stocks in India with a strong roadmap?

Ans. Suraksha Diagnostic, JG Chemicals and Jubilant FoodWorks stand out for their roadmaps in diagnostics, zinc oxide and quick-service restaurants. FY26 revenue growth was 22.5% at Suraksha Diagnostic, 15.2% at JG Chemicals and 17.2% at Jubilant FoodWorks, and return on equity ranges from 12.47% to 18.69%.

Is Suraksha Diagnostic a good stock to buy now?

Ans. Suraksha Diagnostic has a debt to equity ratio of 0.53, a return on equity of 13.15% and a P/E of 46.05 against an industry P/E of 62.79. Valuation, demand and input costs move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of Suraksha Diagnostic, JG Chemicals and Jubilant FoodWorks?

Ans. The P/E ratio is 46.05 for Suraksha Diagnostic (industry 62.79), 31.94 for JG Chemicals (industry 36.60) and 62.77 for Jubilant FoodWorks (industry 61.79). Only Jubilant FoodWorks trades at or above the industry multiple.

Which of these diagnostic chain, zinc oxide maker and pizza chain stocks has the highest return on equity?

Ans. Jubilant FoodWorks has the highest return on equity at 18.69%, followed by Suraksha Diagnostic at 13.15% and JG Chemicals at 12.47%.

What are the risks of investing in diagnostic chain, zinc oxide maker and pizza chain stocks?

Ans. The main risks are debt and cash flow, consumer demand, input costs and quarterly trends. Jubilant FoodWorks has debt to equity of 2.14.

How did Suraksha Diagnostic, JG Chemicals and Jubilant FoodWorks perform in Q1 FY27?

Ans. Suraksha Diagnostic reported revenue of Rs 88.74 crore, up 20.7% year on year, and net profit rose 40.0% to Rs 12.85 crore. JG Chemicals reported revenue of Rs 318.38 crore, up 43.8% year on year, and net profit rose 59.7% to Rs 26.12 crore. Jubilant FoodWorks reported revenue of Rs 2,588.34 crore, up 13.6% year on year, and net profit rose 6.0% to Rs 100.03 crore.

Do diagnostic chain, zinc oxide maker and pizza chain stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 0.02% for Suraksha Diagnostic, 0.16% for JG Chemicals and 0.28% for Jubilant FoodWorks, based on dividends declared for FY26.

How can I invest in diagnostic chain, zinc oxide maker and pizza chain stocks in India?

Ans. You can buy diagnostic chain, zinc oxide maker and pizza chain stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.